Publications

Export 48 results:
Author Title [ Type(Desc)] Year
Filters: Author is Breitner, John  [Clear All Filters]
Journal Article
Picard C, Julien C, Frappier J, Miron J, Théroux L, Dea D, Breitner JCS, Poirier J.  2018.  Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.. Neurobiol Aging. 66:180.e1-180.e9.
Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke CG, Brockschnieder D, Dyrks T, Althoff V, Fraser PE et al..  2015.  Alzheimer amyloid peptide aβ42 regulates gene expression of transcription and growth factors.. J Alzheimers Dis. 44(2):613-24.
Leoutsakos J-M, Gross AL, Jones RN, Albert MS, Breitner JCS.  2016.  'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials.. J Prev Alzheimers Dis. 3(4):229-235.
Binette APichet, Vachon-Presseau E, Morris J, Bateman R, Benzinger T, D Collins L, Poirier J, Breitner JCS, Villeneuve S.  2020.  Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.. Biol Psychiatry.
Rabipour S, Rajagopal S, Yu E, Pasvanis S, Lafaille-Magnan M-E, Breitner JCS, Maria Rajah N.  2020.  APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.. J Alzheimers Dis. 76(1):97-119.
Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner JCS, Dea D.  2014.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.. Neurobiol Aging. 35 Suppl 2:S3-10.
Gonneaud J, Bedetti C, Binette APichet, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S.  2020.  Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease.. Neurology. 95(11):e1554-e1564.
Miron J, Picard C, Labonte A, Auld D, Breitner JCS, Poirier J.  2019.  Association of PPP2R1A with Alzheimer's disease and specific cognitive domains.. Neurobiol Aging. 81:234-243.
Miron J, Picard C, Lafaille-Magnan M-E, Savard M, Labonte A, Breitner JCS, Rosa-Neto P, Auld D, Poirier J.  2019.  Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.. Alzheimers Dement. 15(7):951-960.
Liebsch F, Kulic L, Teunissen C, Shobo A, Ulku I, Engelschalt V, Hancock MA, van der Flier WM, Kunach P, Rosa-Neto P et al..  2019.  Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.. Nat Commun. 10(1):2240.
Meyer P-F, Savard M, Poirier J, Labonte A, Rosa-Neto P, Weitz TM, Town T, Breitner JCS.  2018.  Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.. J Alzheimers Dis. 63(2):577-590.
Vogel JW, Vachon-Presseau E, Binette APichet, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P et al..  2018.  Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.. Brain. 141(6):1871-1883.
Breitner JCS.  2017.  Comment: MCI trials-Categorical "square pegs" in dimensional "round holes"? Neurology. 88(18):1757.
Breitner JCS.  2015.  Comment: Yet another "disconnect" between amyloid and Alzheimer disease? Neurology. 85(8):698.
Tam A, Dansereau C, Badhwar AP, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P et al..  2015.  Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.. Front Aging Neurosci. 7:242.
Tam A, Dansereau C, Badhwar AP, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P et al..  2016.  A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment.. Data Brief. 9:1122-1129.
Tuwaig M, Savard M, Jutras B, Poirier J, D Collins L, Rosa-Neto P, Fontaine D, Breitner JCS.  2017.  Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.. J Alzheimers Dis. 60(4):1589-1600.
Krysinska K, Sachdev PS, Breitner JCS, Kivipelto M, Kukull W, Brodaty H.  2017.  Dementia registries around the globe and their applications: A systematic review.. Alzheimers Dement.
Maysinger D, Ji J, Moquin A, Hossain S, Hancock MA, Zhang I, K Y Chang P, Rigby M, Anthonisen M, Grütter P et al..  2017.  Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on Glia.. ACS Chem Neurosci.
Konishi K, Joober R, Poirier J, MacDonald K, Chakravarty MM, Patel R, Breitner JCS, Bohbot VD.  2018.  Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.. J Alzheimers Dis. 61(4):1493-1507.
Luck T, Riedel-Heller SG, Luppa M, Wiese B, Bachmann C, Jessen F, Bickel H, Weyerer S, Pentzek M, König H-H et al..  2014.  A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study.. Acta Psychiatr Scand. 129(1):63-72.
Tam A, Dansereau C, Iturria-Medina Y, Urchs S, Orban P, Sharmarke H, Breitner JCS, Bellec P.  2019.  A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia.. Gigascience. 8(5)
Meyer P-F, Savard M, Poirier J, Morgan D, Breitner JCS.  2019.  Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology.. Alzheimers Dement. 15(9):1160-1171.
Cavanagh C, Tse YChung, Nguyen H-B, Krantic S, Breitner JCS, Quirion R, Wong TPan.  2016.  Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model.. Neurobiol Aging. 47:41-49.
Meyer P-F, Tremblay-Mercier J, Leoutsakos J, Madjar C, Lafaille-Maignan M-É, Savard M, Rosa-Neto P, Poirier J, Etienne P, Breitner JCS.  2019.  INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.. Neurology. 92(18):e2070-e2080.

Pages